flanders.bio joins forces with FIT to support the internationalisation of Flanders’ economy

 

It’s official: flanders.bio has reached a structural collaboration agreement with Flanders Investment & Trade (FIT), Flanders’ agency for international enterprise. The agreement was signed today by Henk Joos, Managing Director at flanders.bio and Claire Tillekaerts, CEO at FIT, during an official ceremony at the Hotel Errera in Brussels. Flanders’ Minister-President Geert Bourgeois also attended the ceremony, formally sealing the reinforced collaboration. This partnership is embedded within ‘Vlaanderen versnelt!’ (‘Flanders accelerates!’), Flanders’ internationalization strategy.

flanders.bio and FIT will work together closely to support the internationalization plans of Flanders-based businesses even better and in a more streamlined way.

 

Within the life sciences and health cluster internationalisation is crucial. The market for the innovative products developed in the cluster is a world market, and our companies have to look beyond borders to find the expertise and financial resources needed to develop these high-tech products.

 

flanders.bio has a long-standing relationship with FIT when it comes to supporting the international visibility of this Flemish top cluster. This collaboration is very much appreciated by the members of the cluster. Thanks to this partnership flanders.bio will be able to further structure and deepen its international activities on the long term. In this way we can further support the economic growth in Flanders, not only within the core group of life sciences companies but also for the many companies that are providing the essential competences and services to life sciences companies in Flanders and worldwide.

 

In good company

 

In addition to flanders.bio, another 16 organizations will be enhancing their collaboration with FIT. These include business organizations, chambers of commerce, federations and clusters. Each signed an agreement with FIT to help gear up the internationalization of Flanders-based companies:

 

 

 

These structural partnerships are valid for the period of 2017-2021. Their scopes go beyond earlier project-based collaborations, while the funding is split 50/50 between the partners and FIT. Every year, the partnerships will be evaluated based on pre-defined key performance indicators (KPIs). That way, their impacts can be measured objectively.

 

 

Interested in a regular update of the Life Sciences and biotech sector in Flanders?